Detalles de la búsqueda
1.
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
BMC Urol
; 24(1): 96, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658905
2.
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Exp Mol Pathol
; 131: 104860, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36997051
3.
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Acta Oncol
; 62(12): 1880-1889, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938166
4.
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Exp Mol Pathol
; 126: 104762, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35390310
5.
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors.
Ann Diagn Pathol
; 60: 152029, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029589
6.
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer.
Int J Cancer
; 148(3): 748-758, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045100
7.
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Mol Med
; 27(1): 16, 2021 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33588765
8.
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma.
World J Urol
; 39(2): 481-490, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303902
9.
A non-diploid DNA status is linked to poor prognosis in renal cell cancer.
World J Urol
; 39(3): 829-837, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32361874
10.
High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer.
Acta Oncol
; 60(9): 1210-1217, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092167
11.
Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin.
Ann Diagn Pathol
; 54: 151793, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425503
12.
Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.
Med Mol Morphol
; 54(2): 156-165, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33373033
13.
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers.
Int J Cancer
; 147(2): 575-583, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32150281
14.
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer.
Prostate
; 80(13): 1097-1107, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32628300
15.
MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes.
Ann Surg Oncol
; 27(10): 3997-4006, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32108923
16.
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
BMC Cancer
; 20(1): 1220, 2020 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33339518
17.
High homogeneity of MMR deficiency in ovarian cancer.
Gynecol Oncol
; 156(3): 669-675, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31924330
18.
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.
World J Urol
; 38(9): 2185-2196, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31745645
19.
High B7-H3 expression is linked to increased risk of prostate cancer progression.
Pathol Int
; 70(10): 733-742, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776718
20.
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.
World J Surg Oncol
; 18(1): 128, 2020 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32534597